213 related articles for article (PubMed ID: 23477784)
1. Advances in anticancer antibody-drug conjugates and immunotoxins.
Dosio F; Stella B; Cerioni S; Gastaldi D; Arpicco S
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):35-65. PubMed ID: 23477784
[TBL] [Abstract][Full Text] [Related]
2. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
3. Patents on immunotoxins and chimeric toxins for the treatment of cancer.
Bachran C; Sutherland M; Bachran D; Fuchs H
Recent Pat Drug Deliv Formul; 2007; 1(2):105-15. PubMed ID: 19075878
[TBL] [Abstract][Full Text] [Related]
4. Prospects and progress of antibody-drug conjugates in solid tumor therapies.
Govindan SV; Sharkey RM; Goldenberg DM
Expert Opin Biol Ther; 2016 Jul; 16(7):883-93. PubMed ID: 27045979
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates.
FitzGerald DJ; Wayne AS; Kreitman RJ; Pastan I
Cancer Res; 2011 Oct; 71(20):6300-9. PubMed ID: 21998010
[TBL] [Abstract][Full Text] [Related]
7. Antibody drug conjugates - Trojan horses in the war on cancer.
Iyer U; Kadambi VJ
J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the development and manufacturing of antibody-drug conjugates.
Ducry L
Methods Mol Biol; 2012; 899():489-97. PubMed ID: 22735971
[TBL] [Abstract][Full Text] [Related]
9. Antibody drug conjugates: the future of chemotherapy?
Borcoman E; Le Tourneau C
Curr Opin Oncol; 2016 Sep; 28(5):429-36. PubMed ID: 27366963
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells.
Bodey B
Expert Opin Biol Ther; 2001 Jul; 1(4):603-17. PubMed ID: 11727497
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated delivery of therapeutics for cancer therapy.
Parakh S; Parslow AC; Gan HK; Scott AM
Expert Opin Drug Deliv; 2016; 13(3):401-19. PubMed ID: 26654403
[TBL] [Abstract][Full Text] [Related]
12. Antibody-drug conjugates as targeted cancer therapeutics.
Sun Y; Yu F; Sun BW
Yao Xue Xue Bao; 2009 Sep; 44(9):943-52. PubMed ID: 20055167
[TBL] [Abstract][Full Text] [Related]
13. Critical Issues in the Development of Immunotoxins for Anticancer Therapy.
Kim JS; Jun SY; Kim YS
J Pharm Sci; 2020 Jan; 109(1):104-115. PubMed ID: 31669121
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of anticancer immunotoxins.
Choudhary S; Mathew M; Verma RS
Drug Discov Today; 2011 Jun; 16(11-12):495-503. PubMed ID: 21511052
[TBL] [Abstract][Full Text] [Related]
15. Antibody-cytotoxic agent conjugates for cancer therapy.
Chen J; Jaracz S; Zhao X; Chen S; Ojima I
Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components.
Dosio F; Brusa P; Cattel L
Toxins (Basel); 2011 Jul; 3(7):848-83. PubMed ID: 22069744
[TBL] [Abstract][Full Text] [Related]
17. Antibody targeted drugs as cancer therapeutics.
Schrama D; Reisfeld RA; Becker JC
Nat Rev Drug Discov; 2006 Feb; 5(2):147-59. PubMed ID: 16424916
[TBL] [Abstract][Full Text] [Related]
18. Antibody-drug conjugates: basic concepts, examples and future perspectives.
Casi G; Neri D
J Control Release; 2012 Jul; 161(2):422-8. PubMed ID: 22306430
[TBL] [Abstract][Full Text] [Related]
19. Antibody-drug conjugates: Current status and future perspectives.
Gébleux R; Casi G
Pharmacol Ther; 2016 Nov; 167():48-59. PubMed ID: 27492898
[TBL] [Abstract][Full Text] [Related]
20. Antibodies and peptides in cancer therapy.
Khandare JJ; Minko T
Crit Rev Ther Drug Carrier Syst; 2006; 23(5):401-35. PubMed ID: 17425513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
